Edition:
United States

Aakash B

Retrophin scraps nervous system disorder study, shares dive

Aug 22 2019

Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after it failed to improve patients' ability to conduct daily activities such as eating and walking, sending shares down 30%.

Medtronic hits record high as profit beats, raises annual profit outlook

Aug 20 2019

Medtronic Plc beat analysts' estimates for quarterly profit on Tuesday, boosted by higher demand for its surgical instruments and diabetes devices, and the medical device maker raised its forecast for full-year adjusted profit as well.

FDA approves Celgene's bone marrow cancer treatment

Aug 16 2019

The U.S. Food and Drug Administration on Friday approved Celgene Corp's Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease.

Deciphera shares skyrocket as cancer drug improves progression-free survival

Aug 13 2019

Deciphera Pharmaceuticals Inc's shares more than doubled on Tuesday after the drugmaker said its treatment helped stomach cancer patients live longer without their disease worsening in a late-stage study.

Humana raises 2019 profit forecast on back of second-quarter beat

Jul 31 2019

Health insurer Humana Inc raised its 2019 profit forecast on Wednesday and beat second-quarter earnings estimates, as it reined in costs and recorded higher revenue from its unit that sells Medicare Advantage health plans.

Merck's treatment for urinary, abdominal infections gets FDA approval

Jul 17 2019

The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

Merck's treatment for urinary, abdominal infections gets FDA approval

Jul 17 2019

July 17 The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday.

Walgreens beats estimates on prescription drug sales, shares rise

Jun 27 2019

Walgreens Boots Alliance Inc on Thursday posted a better-than-expected quarterly profit as the drugstore chain benefited from a rise in branded drug prices and an increase in the number of prescriptions it fills in the United States.

World News